Navigation Links
Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Date:10/23/2007

Maximum tolerated dose for trodusquemine determined

PLYMOUTH MEETING, Pa., Oct. 23 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today presented data from its dose-escalating Phase 1 clinical trial of trodusquemine (Study MSI-1436C-101), the Company's product candidate for the treatment of obesity. In the study, trodusquemine was found to be well-tolerated at likely clinical doses, and no serious adverse events were seen in healthy overweight and obese adults. Data were presented in a poster at the North American Association for the Study of Obesity (NAASO) Annual Meeting in New Orleans, Louisiana.

Genaera also announced today that the Company has designated 40 mg/m2 of trodusquemine as the maximum tolerated single dose for subjects in Study 101, as a result of nausea. The Company plans to move forward with evaluations of single doses of trodusquemine within the likely clinically effective range for the drug in type 2 diabetics then proceed to study the safety and pharmacokinetics of the drug in several multiple dose scenarios.

Study MSI-1436C-101, the first trodusquemine Phase 1 trial and the subject of today's poster session, is a double-blind, randomized, placebo-controlled, single-group assignment safety study with seven subjects per group enrolled in sequential dose groups of healthy overweight or obese adult male and female volunteers who have a body mass index (BMI) of 27-40. Five subjects in each dosing group received trodusquemine while the other two subjects in the dosing group received placebo. Participants were studied at a single center, to evaluate the safety, tolerability and pharmacokinetics (PK) of a single intravenous dose of trodusquemine. The study began wi
'/>"/>

SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
2. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
3. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
4. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
5. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
6. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
7. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 The U.S. Food and Drug ... as an option for the treatment of schizophrenia and ... in adolescents aged 13-17 years old. ,, The ... consideration the increased potential for weight gain and hyperlipidemia ...
(Date:12/4/2009)... Dec. 4 Amber Pharmacy announced today that it ... Inc. (ACHC) for specialized pharmacy services. For nearly 15 ... and services to meet the unique needs of specialized ... of services to transplant programs. They work with over ...
(Date:12/4/2009)... STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, ... systems and service programs for hospitals and healthcare ... The Joint Commission,s Accreditation for Ambulatory Health Care, ... quality and safety in patient care. Shared Imaging ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 1GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 3President Obama Misleads Public on Health Care for Illegal Aliens 3B Illegal Aliens Would Benefit Under H R 3200 56859 1President Obama Misleads Public on Health Care for Illegal Aliens 3B Illegal Aliens Would Benefit Under H R 3200 56859 2California Nurses NNOC Nations Largest Nurses Organization Unanimously Endorses Joining RN Super Union 56856 1California Nurses NNOC Nations Largest Nurses Organization Unanimously Endorses Joining RN Super Union 56856 2
... Bcl-2 Antagonist shown to be therapeutically effective ... , COPENHAGEN, 18 April 2007 - Santaris ... yesterday,presented encouraging data at the American Association ... showing that SPC2996, the,Company's RNA Antagonist of ...
... -- Kosan,Biosciences Incorporated today presented preclinical data ... induction of,potent, fast-acting and long-lasting anticancer activity ... human tumor xenograft,cancer models. , Kosan's NEIs ... highly,conserved, essential protein that exports key regulatory ...
Other Medicine Technology:Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 2Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 3Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 4Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 5Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 6Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 2Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 3Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR 4
(Date:12/5/2009)... wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay ... 40th birthday without ever tying the knot, since research has ... folks. And, um, isn,t there something wrong with those who ... new study looking at psychological measures shows that never-married people ...
(Date:12/5/2009)... most unusual places, and to do everything from growing mushrooms, making wine ... ... Who would have thought that your wine, water and vegetables would have ... a new line of turbines, for industry end users, not wind farms. ...
(Date:12/4/2009)... FRANCISCO, Dec. 4 Medithrive, Inc. has won the ... SF Bay Area by popular vote conducted by the ... in operation, the SF Bay community has selected Medithrive ... ,, The rapid rise and popularity of Medithrive ...
(Date:12/4/2009)... two-day free health clinic sponsored by the National Association of ... is not just for the sick but also for anyone ... All participants in the health clinic will receive preventive primary ... large free clinic events this fall in Houston, New Orleans ...
(Date:12/4/2009)... Dec. 4 In response to the ... classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as ... (CSA), John Gay, executive director and CEO ... oldest and largest trade association representing ...
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
... finding, researchers using brain scans have uncovered evidence of ... known as// hysteria. The study’s findings open up a ... in which a patient complains of symptoms, but doctors ... ,The study involved three women with sensory conversion ...
... (OSA) may improve their memory by using continuous positive ... majority of patients// with OSA, who were memory-impaired prior ... of optimal CPAP use. The study also showed that ... used CPAP for at least 6 hours a night ...
... San Mateo Seniors quarantine 3 more medical facilities after the ... year than the// past. ,San Mateo County health ... already sickened dozens of people in a Belmont senior living ... doctors added that the outbreak is being reported more this ...
... rapidly achieves sharp reductions in human immunodeficiency virus (HIV) ... for patients with HIV infection. ,If the ... should clearly be a welcome addition to the existing ... the new study, led by Dr Martin Markowitz of ...
... Britain's leading scientists have supported the use of primates ... deaths// from disease. But only if no alternatives were ... the use of primates, Lead author of the report, ... are essential to answer scientific questions because other animals ...
... have explored whether tai chi, balance programs and fitness ... will fall and injure themselves. Many of these programs ... open to debate. ,Now, a study from ... the Veterans Affairs Ann Arbor Healthcare System suggests that ...
Other Medicine News:Health News:Memory Improves After Sleep Apnea Therapy 2Health News:Quarantine Hits 3 More Hospitals In San Mateo 2Health News:New Drug Offers Promise as Single Treatment for HIV 2Health News:Britain Scientists Support the Use of Primates in Research 2Health News:Balance Training Better Than Tai Chi at Improving Mobility in Older Adults 2Health News:Balance Training Better Than Tai Chi at Improving Mobility in Older Adults 3
Volk indirect lenses. General diagnosis & treatment....
... contact class is particularly suitable ... which have a smaller distance ... reduction prism than the Haag-Streit ... / iridocornea. Mirror angle 59° ...
Precision has its new line of programmable autoclaves which are easy to use bench-top autoclaves or models to fit any need. It has 4 adjustable sterilization programs, touch button control panel, man...
... one touch design all of your ... The Tuttnauer fully automatic autoclaves fill, ... touch of a button. All EA ... door active drying system to maintain ...
Medicine Products: